Daniel R. Wahl, Ph.D.
Affiliations: | 2012 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
anti-DNA autoantibody structure and function, and the identification of novel molecular targets and small molecules for the treatment of autoimmune diseases and cancerGoogle:
"Daniel Wahl"Mean distance: 8.64
Parents
Sign in to add mentor| Gary D. Glick | grad student | 2012 | University of Michigan | |
| (Exploiting the Bioenergetics of Disease-Causing Lymphocytes for Selective Immunomodulation.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Valvo VM, Zhang Q, Jiang L, et al. (2024) Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancreatic Cancer. Molecular Cancer Therapeutics. OF1-OF16 |
| Bell HN, Huber AK, Singhal R, et al. (2022) Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer. Cell Metabolism |
| Werner CK, Nna UJ, Sun H, et al. (2020) Expression of the of the androgen receptor governs radiation resistance in a subset of glioblastomas vulnerable to anti-androgen therapy. Molecular Cancer Therapeutics |
| Chung C, Sweha SR, Pratt D, et al. (2020) Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas. Cancer Cell |
| Zhou W, Yao Y, Scott AJ, et al. (2020) Purine metabolism regulates DNA repair and therapy resistance in glioblastoma. Nature Communications. 11: 3811 |
| Michmerhuizen AR, Chandler B, Olsen E, et al. (2020) Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells. Frontiers in Endocrinology. 11: 35 |
| Nelson BS, Lin L, Kremer DM, et al. (2020) Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy. Cancer & Metabolism. 8: 1 |
| Halbrook CJ, Wahl DR, Lyssiotis CA. (2019) Running the Light: Nucleotide Metabolism Drives Bypass of Senescence in Cancer. Trends in Biochemical Sciences |
| Lang X, Green MD, Wang W, et al. (2019) Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discovery |
| Zhou W, Wahl DR. (2019) Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance. Cancers. 11 |